Euro
USD
British Pound
NULL
Product Description
Brolucizumab (VEGFA) Antibody, Monoclonal | 10-687 | ProSci
Host: N/A
Reactivity: N/A
Homology: N/A
Immunogen: Humanized / VEGFA [Homo sapiens]
Research Area: Drug Analogues
Tested Application: N/A
Application: N/A
Specificiy: N/A
Positive Control 1: N/A
Positive Control 2: N/A
Positive Control 3: N/A
Positive Control 4: N/A
Positive Control 5: N/A
Positive Control 6: N/A
Molecular Weight: N/A
Validation: N/A
Isoform: N/A
Purification: >95%
Clonality: Monoclonal
Clone: N/A
Isotype: scFv-kappa-heavy
Conjugate: Unconjugated
Physical State: N/A
Buffer: PBS buffer pH7.5
Concentration: N/A
Storage Condition: Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8 ˚C for 1-2 weeks. Store at -20 ˚C for 12 months. Store at -80 ˚C for long term storage.
Alternate Name: ESBA-1008, ESBA1008, RTH258
User Note: Optimal dilutions for each application to be determined by the researcher.
BACKGROUND: Brolucizumab, also known as RTH258 or ESBA1008, 4 is a monoclonal antibody indicated to treat neovascular age related macular degeneration.Brolucizumab was granted FDA approval in October 2019.6.
